IVF hartmann Holding AGXSWX:VBSN -0.79%74 Days Payable is 66.57 as of Dec. 2025, which is 1% below its 10-year median of 67.26. GuruFocus rates XSWX:VBSN with a GF Score™ of 74/100 and a GF Value™ of CHF143.11 (Modestly Undervalued). Among 795 Medical Devices & Instruments companies, IVF hartmann Holding AG ranks worse than 51.32% on this metric.
The historical rank and industry rank for IVF hartmann Holding AG's Days Payable or its related term are showing as below:
XSWX:VBSN'
s Days Payable Range Over the Past 10 Years
Min: 61.83 Med: 67.26 Max: 79.04
Current: 67.26
During the past 13 years, IVF hartmann Holding AG's highest Days Payable was 79.04. The lowest was 61.83. And the median was 67.26.
XSWX:VBSN's Days Payable is ranked worse than 51.32% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs XSWX:VBSN: 67.26
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:VBSN vs ISRG, BDX, MDLN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, IVF hartmann Holding AG's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IVF hartmann Holding AG Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, IVF hartmann Holding AG's Days Payable distribution charts can be found below:
* The bar in red indicates where IVF hartmann Holding AG's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
IVF hartmann Holding AG's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IVF hartmann Holding AG (XSWX:VBSN) has a Days Payable of 66.57 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on IVF hartmann Holding AG and its competitors. This is near median its historical median of 67.26. Over the past decade, IVF hartmann Holding AG's Days Payable has ranged from 61.83 to 79.04. According to the industry distribution chart, IVF hartmann Holding AG ranks #408 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 51.3%.
Is IVF hartmann Holding AG's Days Payable too high?
IVF hartmann Holding AG's current Days Payable of 66.57 is near median its 10-year median of 67.26. Over the past 10 years, this metric has ranged from a low of 61.83 to a high of 79.04. The Medical Devices & Instruments industry median Days Payable is 68.07. IVF hartmann Holding AG's value of 66.57 is 2.2% below this industry median. Based on the distribution chart, IVF hartmann Holding AG ranks #408 out of 795 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, IVF hartmann Holding AG has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IVF hartmann Holding AG's Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, IVF hartmann Holding AG ranks #408 out of 795 companies for Days Payable. This places IVF hartmann Holding AG in the lower half of its industry. The industry median Days Payable is 68.07. IVF hartmann Holding AG's value of 66.57 is 2.2% below this benchmark. Historically, IVF hartmann Holding AG's own Days Payable has ranged from 61.83 to 79.04 over the past decade. While the company's 10-year median is 67.26 vs. the industry median of 68.07, IVF hartmann Holding AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IVF hartmann Holding AG's current Days Payable of 66.57 is 2.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on IVF hartmann Holding AG and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IVF hartmann Holding AG's current Days Payable is 66.57, which is near median its own 10-year median of 67.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IVF hartmann Holding AG stock overvalued right now?
Based on GuruFocus' analysis, IVF hartmann Holding AG (XSWX:VBSN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF143.11, compared to a current price of CHF125.00 — trading 12.7% below its estimated fair value. The current Days Payable is 66.57, which is near median its 10-year median of 67.26 and 2.2% below the Medical Devices & Instruments industry median of 68.07. IVF hartmann Holding AG's overall GF Score™ is 74/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For IVF hartmann Holding AG (XSWX:VBSN), the current Days Payable is 66.57 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IVF hartmann Holding AG (XSWX:VBSN) Overvalued in 2026?
Based on GuruFocus' analysis, IVF hartmann Holding AG stock appears to be undervalued.
The current stock price of CHF125.00 is trading 12.7% below its estimated GF Value™ of CHF143.11.
GuruFocus considers IVF hartmann Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:VBSN:
Days Payable: 66.57 (near median its 10-year median of 67.26)
GF Value™: CHF143.11 vs. price of CHF125.00 (12.7% below fair value)
Industry Position: 2.2% below the Medical Devices & Instruments median (#408 of 795)
No single metric tells the full story. See the XSWX:VBSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IVF hartmann Holding AG engages in production and supply of medical, pharmaceutical and hygiene products in Switzerland, it offers products such as surgical disposable, disposable dental, first aid, therapeutic plaster, cotton wool, wound care among others. The company operates in four segment wound care, incontinence management, infection management and Other group activities.
74GF Score
Get the complete analysis for XSWX:VBSN
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:VBSN has been successfully added to your 
